Presentations Wolfheze Workshops 2017

Wednesday 31 May 2017

Update on the first WHO TB Global Ministerial Conference European Region (English, Russian)

SESSION 1: WHO European Region TB Action Plan 2016-2020 and country progress in adaption and implementation with focus on migrants:
1.1)-Update on implementation of WHO European Region TB-AP 2016-2020.  M. Dara (English, Russian)
1.2)-Key partners update on working with vulnerable groups with focus on migration. Marieke v.d. Werf (English, Russian)

SESSION 2: TB/HIV collaborative activities:
2.1)-Presentation on TB/HIV surveillance data Europe. Andrei Dadu (English, Russian)
2.2 -Presentation of the results of the survey on TB/HIV collaborative activities in the European Region. Gerard de Vries (English, Russian)
2.3-Presentation on ‘Integrated TB/HIV care from a clinicians perspective. Reinout van Crevel. (English, Russian)

Thursday 1 June 2017


SESSION 3: Latent TB infection:
3.1-WHO recommended M&E framework of LTBI programmatic Management. Andrei Dadu (English, Russian)
3.2Presentation Development of the guidance on programmatic LTBI control in the EU/EEA. Dominik Zenner/Gerard de Vries (English, Russian)
3.3-Country presentations:
– Germany. Barbara Hauer (English, Russian)
– Sweden. Judith Bruchfeld (English, Russian)
– Estonia, Piret Viiklepp (English, Russian)
– Finland, Tuula Vasankari (English, Russian)
-Kazakhstan (English, Russian)

SESSION 4: Putting quality into people-centred care: A focus on the patient experience
4.1 What is quality People-Centred Care? Evgenia Geliukh, (Russian, English)
4.2- + 4.3 presentation Timur Abdullaev and Tatyana Zhugan (English, Russian)
4.4-What do we mean by integrated, community-based treatment and support? An example from Romania. Jonathan Stillo (English, Russian)
4.5. Increasing understanding of civil society organisations and their use in TB care. A proposal for training of NTP and senior TB care providers. Paul Sommerfeld (English, Russian)

SESSION 5: New and repurposed anti-TB drug introduction and active TB drug-safety monitoring and management (aDSM)

5.1 -Update aDSM state-of-the art. Ernesto Jaramillo (English, Russian).
5.2 -Joint Key partners’ update, including a country example, on contributions to new and re-purposed drug introduction and aDSM. (Russian, English)

5.3 -Country presentations Kyrgyzstan. Abdullaat Kadyrov (English, Russian)
5.4 -Country presentations Belarus. Alena Skrahina (English, Russian)

Friday 2 June 2017

SESSION 6: Digital Health
6.1 -Digital Technology to end TB: the current state, evidence and solutions. Dennis Falzon (English, Russian).
6.2 -Digital Technology to end TB: the current state, evidence and solutions. Kristian van Kalmthout (English, Russian)
6.3 -Digital Health application in learning (ePAL), patient care (eTB-consilium) and surveillance (TB cross-border). Svetlana Pak (English, Russian)
6.4-mVOT in London. Alena Skrahina  (English, Russian)
6.5 -mVOT in Belarus. Al Story (English, Russian)

SESSION 7: Reporting on other Wolfheze activities and news from the organizations. Next steps Wolfheze Workshops 2017

-7.1 Reporting on other Wolfheze activities. English, Russian
-7.2 Update about the TB-REP project, English, Russian.
-7.3 Update about the European Research Initiative (ERI). English, Russian
-7.5 Guidance on diagnosis, treatment, care and prevention of tuberculosis in prison settings. English, Russian
-7.6 Update -DETECT project. English
-7.8 Ethics Asessment Tool and Training curriculum. English, Russian

KNCV has been fighting TB since its establishment in 1903. Over the past 120 years, the organization has acquired indispensable knowledge and experience in the field of effective TB prevention and care, resulting in pre-elimination in the Netherlands and significant contributions to global evidence generation, policy development and TB program implementation worldwide.

Our experts
KNCV governance framework and integrity
Our patroness
Partner with us

Sorry

De versie van de browser die je gebruikt is verouderd en wordt niet ondersteund.
Upgrade je browser om de website optimaal te gebruiken.